Knowledge and Awareness Among Patients with Chronic Kidney Disease Stage 3 by Welch, Janet L. et al.
Nephrology Nursing Journal November-December 2016 Vol. 43, No. 6 513
Knowledge and Awareness Among
Patients with Chronic Kidney Disease
Stage 3 
Chronic kidney disease (CKD) isa public health problem affect-ing 14% of the general UnitedStates (U.S.) population. Mor -
tality rates among Medicare patients
with CKD are higher than for patients
without CKD, and hospitalization
rates increase with advancing disease
(United States Renal Data System
[USRDS], 2015). The acquisition of
knowledge is an important prerequi-
site for self-management that can be
used to improve outcomes and re -
duce mortality rates. For example,
Wright-Nunes, Luther, Ikizler, and
Cavanaugh (2012) reported that ac -
quiring knowledge about goal blood
pressure was an independent predic-
tor of patients achieving blood pres-
sure control; Devins, Mendelssohn,
Barré, Taub, and Binik (2005) report-
ed pre-dialysis education improved
pa tient survival.
The purpose of this article is to
des cribe knowledge of CKD and its
treatment in a sample of patients with
CKD Stage 3 who had coexisting dia -
betes and hypertension. The follow-
ing research aims were addressed: 1)
to examine the CKD knowledge level
of patients with CKD Stage 3, and 2)
to assess awareness of a CKD diagno-
sis. 
Background 
Self-management in the early
stages of CKD targets delaying pro-
Janet L. Welch
Rebecca J. Bartlett Ellis
Susan M. Perkins
Continuing Nursing
Education
gression to more advanced disease
and improving outcomes. Slowing the
progression of CKD requires perform-
ance of key self-management behav-
iors, including adherence to medica-
tions known to slow disease progres-
sion (angiotensin-converting enzyme
inhibitors [ACEI] or angiotensin
receptor blockers [ARB]), avoidance
of nonsteroidal anti-inflammatory
drugs, blood pressure control, gly -
cemic control, regular exercise, diet,
and tobacco avoidance (Agency for
Healthcare Research and Quality
[AHRQ], 2012; Chadban et al., 2010;
Pellicano, Kerr, & Atkins, 2005; Solini
& Ferrannini, 2011; Tuot et al., 2013).
Self-management is associated with
ad herence to healthy lifestyles
(Walker, Marshal, & Polaschek, 2013),
better glomerular filtration rate (GFR)
(Chen et al., 2011), blood pressure
control (Walker et al., 2013), improved
medication adherence (Walker et al.,
2013), reduced proteinuria (Walker et
al., 2013), and fewer hospitalizations
(Chen et al., 2011). 
Although existing self-manage-
ment programs for patients with CKD
and other chronic diseases, such as
diabetes, hypertension, and heart fail-
ure, often demonstrate improved out-
comes (Barnason, Zimmerman, &
Young, 2012; Boren, Wakefield,
Gunlock, & Wakefield, 2009; Cueto-
Manzano, Martinez-Ramirez, Cortes-
Sanbria, 2010; Jovicic, Holroyd-
Leduc, & Straus, 2006), enhancing
CKD knowledge remains a challenge.
Such knowledge includes general
knowledge about CKD, such as the
causes, risks for development, and fac-
tors associated with progression
(Plantinga, Tuot, & Powe, 2010). In
one cross-sectional survey of 210
patients who received care at least
three times from a nephrologist over
12 months, 23% identified alcohol as
the most common cause of CKD, 44%
reported they did not know the com-
mon causes of CKD, and 38% were
unsure about the treatment for CKD
(Gray, Kapojos, Burke, Sammartino,
& Clark, 2016). African Americans are
at higher risk for CKD than other
populations, yet knowledge remains
remarkably low in this particular pa -
tient population. For example, Kazley,
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Knowledge is a prerequisite for changing behavior, and is useful for improving outcomes
and reducing mortality rates in patients diagnosed with chronic kidney disease (CKD).
The purpose of this article is to describe baseline CKD knowledge and awareness
obtained as part of a larger study testing the feasibility of a self-management interven-
tion. Thirty patients were recruited who had CKD Stage 3 with coexisting diabetes and
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Participants had a moderate amount of CKD knowledge. This study suggests the need to
increase knowledge in patients with CKD Stage 3 to aid in slowing disease progression. 
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Johnson, Simpson, Chavin, and
Baliga (2015) found that a majority of
African Americans participating in
focus groups were unaware of risk
factors for and causes of CKD, and
were unsure of treatments available
for CKD.
The ability of patients to acquire
knowledge and to self-manage may
be limited by disease awareness,
including knowledge of CKD and
knowledge about CKD self-manage-
ment (Lopez Vargas et al., 2014).
Patients are often unaware of their
kidney dysfunction and disease diag-
nosis (Plantinga et al., 2010; Tout et
al., 2011; Wright, Wallston, Elasy,
Ikizler, & Cavanaugh, 2011). Accord -
ing to a National Health and Nutri -
tion Examination Survey (Centers for
Disease Control and Prevention
[CDC], 2012), only about 50% of peo-
ple with CKD across all age groups
were aware they had the disease, and
fewer than 15% of people in Stages 3
and 4 CKD were aware of their kid-
ney disease. 
Methods 
Design 
The self-management support
component of the Chronic Care
Model provided the overarching the-
oretical framework for the study
because it emphasizes the central role
patients have in managing their own
care (Wagner, Davis, Schaefer, Von
Korff, & Austin, 1999). Knowledge is
a prerequisite when providing self-
management support and helping
patients to manage their own care. 
This report presents baseline
knowledge and is taken from a larger
study testing the feasibility of a self-
management intervention. Baseline
data were collected at entry into the
study. All participants received the
usual care provided in a large renal
clinic, including outpatient office vis-
its, review of laboratory values,
review of all prescribed medical ther-
apeutics, and recommended changes
to the regimen. Routine nursing care
included measurement of weight and
blood pressure. 
Recruitment and Sample
Participants were eligible if they
a) had CKD Stage 3 with coexisting
diabetes and hypertension, b) were 18
years of age or older, c) spoke
English, d) were alert and oriented, e)
were willing to use technology in the
home, f) were able to open a pill bot-
tle, g) self-administered medications,
and h) lived in a county served by
Indiana University Home Health
Care Indianapolis. Patients were
excluded if they a) lived in an assist-
ed-living or extended-care facility, or
b) had a score of less than 5 on the 6-
item Cognitive Impairment Screener
(Callahan, Unverzagt, Hui, Perkins, &
Hendrie, 2002). 
Following approval from the
Institutional Review Board (IRB),
recruitment began in February 2014
and was completed in October 2015.
The recruitment plan evolved over
time and included the distribution of
a flyer during check-in; engaging the
services of the Research Network
(ResNet) at the Indiana Clinical Trans -
lational Sciences Institute (CTSI),
which identified patients using the
Indiana Network for Patient Care
(INPC) electronic medical record
database; and altering the process for
obtaining baseline data collection to
reduce time from consent to group
assignment. The study was explained
to all potential participants, questions
were answered, consent and the
authorization for the release of health
information were obtained, and eligi-
bility was confirmed. 
Procedures 
Data collectors were registered
nurses, and all received approximate-
ly four hours of study-specific, one-
on-one training in a private and quiet
office by the primary investigator (PI)
or project manager using a training
manual developed for the project.
Training for ResNet staff was provid-
ed by the recruitment director of
ResNet. Training included a) general
information about the study (contact
information, study overview, struc-
ture, human subjects training, use of
technology); and b) role-specific in -
formation (position description, re -
cruitment and informed consent, data
collection, use of an electronic data-
base for data entry, proper use of
back-up paper copies, self-evaluation
form). Competency was assessed by
practicing and role-playing in a pri-
vate office. All data collectors were
provided with phone numbers to call
for any questions. 
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Data collectors read question-
naire items to participants over the
telephone and recorded their res -
ponses. All data were directly entered
into REDCap (Research Electronic
Data Capture), a secure Internet
application for building and manag-
ing online surveys and databases
(Harris et al., 2009). Approximately
one interview per participant was
audio-recorded for quality assurance
and then destroyed. Data from the
medical record were collected follow-
ing baseline data collection. 
Measures 
Knowledge. Knowledge was
assessed using the Kidney Knowledge
Survey, a 28-item scale designed to
assess knowledge specific to CKD in
those who do not require kidney
replacement therapy. Knowledge
scores are computed by adding the
number of correct responses divided
by total number of questions and
multiplying by 100 to obtain a per-
centage score. Non-response was
scored as incorrect. The items most
often skipped were the meaning of
GFR (n = 8), risk of cardiovascular
disease (n = 4), serum potassium lev-
els (n = 4), unusual itching (n = 4),
effect of proteinuria (n = 3), medica-
tions harmful to kidney (n = 3), bone
health (n = 3), and serum phosphorus
levels (n = 3). Higher scores indicate
more knowledge. Internal consisten-
cy was reported as 0.72 in past
research using the Kuder-Richardson-
20 (Wright et al., 2011). Internal con-
sistency reliability of the knowledge
scale at baseline was 0.76 in this study. 
CKD awareness. Awareness
was assessed using one dichotomous
item: “Do you have kidney disease?”
Demographic and clinical
data. A general information question-
naire was used to collect information
about demographic and clinical fac-
tors (e.g., age, race, level of education).
Data Analysis 
All data analyses were conducted
using SAS, Version 9.4 (Cary, NC).
Descriptive statistics were used to
analyze all study variables and to
address the research aims. 
Results 
Sample 
As shown in Table 1, the conven-
ience sample of 30 participants were
predominantly female, black, not
Hispanic or Latino, educated beyond
high school, married, and nonsmok-
ers. There were no significant differ-
ences in age, gender, or race between
participants and those who were eligi-
ble but chose not to enroll. 
Knowledge 
Participants in this study had a
moderate amount of CKD knowl-
edge. The mean score was 64.8% (SD
= 16.2) out of a possible maximum
score of 100%. Knowledge scores
ranged from 17.8% to 82.1%. 
Table 2 displays the correctly
answered CKD knowledge items in
rank order. More than 75% of the
sample had general knowledge that
included CKD stages, mortality risk,
and treatment for kidney failure;
knew they could take medications to
preserve kidney health; were able to
identify three functions of the kidney,
including cleansing the blood, keep-
ing red blood cell counts normal, and
maintenance of blood pressure; knew
the kidneys did not function to pre-
vent hair loss; and identified symp-
toms associated with CKD, including
fatigue and nausea/vomiting. 
Of the study participants, 72.4%
could correctly identify target blood
pressure, 69.0% knew they were at
risk for cardiovascular disease, and
55.2% knew that some medications
could cause additional harm to the
kidney. Three additional functions of
the kidney were identified, including
maintenance of a normal serum
potassium, making urine, and keep-
ing serum phosphorus normal.
Symptoms commonly associated with
CKD were identified, including trou-
ble sleeping, weight loss, metal or bad
taste in mouth, shortness of breath,
and unusual itching. 
In addition, 31.0% knew the
meaning of “GFR,” and 10.0% knew
the effects of proteinuria on the kid-
ney. With regard to the additional
functions of the kidney, 44.8% identi-
fied keeping blood sugar normal, and
37.9% identified keeping bones
healthy. Confusion was identified as a
symptom associated with CKD by
48.3% of participants; however,
55.2% of participants did not know
that CKD may be entirely asympto-
matic, especially in its early stages. 
Awareness
Of the 28 participants who res -
ponded to this item, 54.0% were un -
aware of their CKD diagnosis.
Discussion 
Overall, participants had moder-
ate levels of knowledge about their
disease. The mean total scale score
reported in the present sample
(64.8%; SD = 16.2) was comparable
to the mean score of 66.0% (SD =
15.0) reported by Wright et al. (2011)
who developed and psychometrically
tested the Kidney Knowledge Survey.
More than half of participants (54.0%)
were unaware of their kidney disease,
a finding consistent with the poor
awareness of kidney disease re ported
in the general U.S. population
(USRDS, 2015). Unfortunately, this
lack of awareness was present despite
receiving care by a nephrologist.
Although the Kidney Disease
Knowledge Survey is designed as a
total scale score, there are some
important items on the survey on
which participants in this sample
scored well. In particular, the sample
had relatively greater knowledge
(75% or more correct) about mortality
risk, stages of CKD, many of the func-
tions of the kidney, medications used
to preserve the kidney, and symp-
toms, including fatigue, nausea,
and/or vomiting. Participants scored
high on these knowledge items des -
pite patients being unaware of their
own diagnosis of CKD. These results
may reflect public awareness cam-
paigns and national efforts to increase
knowledge in this area. However, the
lack of awareness by individual
patients of their own disease may
reflect a gap in patient-provider com-
munication. This lack of awareness
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has been reported in other studies. In
a sample of 109,285 participants
receiving primary care, Whaley-
Connell and colleagues (2012) report-
ed that only 9% were aware of their
diagnosis and McIntyre, Fluck,
McIntyre, and Taal (2012) found that
41% of patients referred to nephology
care were unaware of their diagnosis.
Non-disclosure of CKD may be a
problem for providers. In particular,
communicating the diagnosis and dis-
cussing its implications may be stig-
matizing to patients and practitioners
have reported difficulty in disclosing
a CKD diagnosis (Crinson, Gallagher,
Thomas, & de Lusignan, 2010). 
Items about which patients in this
sample had the least knowledge
included knowledge about kidney
function as important for keeping
blood sugar normal and bones
healthy, as well as symptom items
including confusion and whether
CKD was associated with symptoms at
all. Given the significant relationship
between diabetes and CKD, the poor
knowledge in this area suggests a need
to improve patient understanding
about the connection bet ween blood
glucose levels and kidney function.
Participants scored the poorest
on two additional items: understand-
ing the acronym GFR and the effects
of proteinuria. Although these labora-
tory values are closely monitored in
CKD clinics, these medical terms are
complex, and we should not be sur-
prised when patients do not fully
understand their meaning or the rela-
tionship of GFR and proteinuria to
CKD management. However, the
lack of knowledge about these two
clinical terms may reflect low health
literacy, that is, the ability to process
and understand health-related infor-
mation (Devraj & Gordon, 2009). 
These findings challenge provi -
ders to discover how to present infor-
mation in ways that are comprehensi-
ble to all patients.
Limitations
A small convenience sample was
obtained from one large, urban,
Midwestern city. A larger sample
from more diverse areas will be need-
ed to promote generalizability. 
Implications for Nursing Practice 
Despite these limitations, this
study provides important information
in which more patient education is
needed. It is critical for patients to first
understand their own diagnosis of
CKD. Because patients in CKD Stage
3 are at risk for repeated healthcare
encounters and hospitalizations
(Welch, Meek, Bartlett Ellis, Ambuehl,
& Decker, in review), it is critical that
these patients are aware of their diag-
nosis and ways that they can self-
manage to slow the progression of
CKD. Future trials may want to con-
sider including an awareness arm as
part of their design before testing an
educational intervention. 
It is important to assess whether
patients comprehend the information
Table 1 
Summary of Demographic and Clinical Variables
Variable n % Mean Median SD Min Max
Age 30 59.7 60 9 38 74
eGFR (MDRD equation) 28 45.5 46 9.1 31 59
Sex
Female 19 63
Male 11 37
Race
Black or African American 18 60
White 12 40
Ethnicity
Hispanic or Latino 0 0
Not Hispanic or Latino 30 100
Education
Less than high school 3 10
High school graduate 11 37
Some college 12 40
College degree 1 3
Post-college 3 10
Marital status
Single 4 13
Married 10 33
Living with someone 0 0
Divorced 9 30
Separated 4 13
Widowed 3 10
Aware of CKD diagnosis
Yes 13 46
No 15 54
Current smoker
Yes 6 20
No 24 80
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communicated to them by healthcare
providers. Participants in our sample
were relatively well-educated and had
some general knowledge of the dis-
ease, which is useful when communi-
cating both with healthcare providers
and their significant others. However,
presenting information in a way that
is understood by patients may be
challenging for some, especially when
unfamiliar language is used. The
teach-back method is one approach
that can assist healthcare providers in
assessing how well patients under-
stand. One approach to using the
teach-back method is to help prepare
patients for how they might commu-
nicate the diagnosis to their loved
ones, saying, for example: “I know I
have shared a lot of information with
you today. You might want to share
this information with your family.
How might you explain to them what
we discussed here today?” An open-
ended question like this helps patients
to process information and prepares
them to explain their diagnosis to
their family members. An inability to
repeat or paraphrase this information
back to the provider may suggest they
need further support understanding
their diagnosis or that they have fur-
ther concerns about their diagnosis
that can be addressed. 
Having patients acquire knowl-
edge is an important first step in CKD
Table 2
Correctly Answered Chronic Kidney Disease Knowledge Items in Rank Order at Baseline
Rank
Order CKD Knowledge Items
Number Answering
Item Correctly Percentage
1 Mortality risk 28 96.55
2 Symptom: increased fatigue 27 93.10
3 Treatment for kidney failure 26 89.66
4 Medications that preserve kidney health 25 86.21
5 Stages of chronic kidney disease 25 86.21
6 Function of kidney to clean blood 24 82.76
7 Function of kidney to keep red blood cell count normal 23 79.31
8 Function of kidney to keep blood pressure normal 23 79.31
9 Function of kidney to keep from losing hair 22 75.86
10 Symptom: nausea and/or vomiting 22 75.86
11 Target blood pressure 21 72.41
12 Function of kidney to keep serum potassium normal 21 72.41
13 Cardiovascular disease risk 20 68.97
14 Symptom: trouble sleeping 20 68.97
15 Symptom: weight loss 20 68.97
16 Symptom: hair loss 19 65.52
17 Function of kidney to make urine 18 62.07
18 Symptom: metal/bad taste in mouth 17 58.62
19 Medications that can hurt the kidney 16 55.17
20 Symptom: shortness of breath 16 55.17
21 Function of kidney to keep serum phosphorus normal 15 51.72
22 Symptom: unusual itching 15 51.72
23 Symptom: confusion 14 48.28
24 Function of kidney to keep blood sugar normal 13 44.83
25 Symptoms: no symptoms at all 13 44.83
26 Function of kidney to keep bones healthy 11 37.93
27 Meaning of acronym “GFR” 9 31.03
28 Effect of proteinuria 3 10.34
Note: n = 29. One person did not complete the Kidney Knowledge Survey.
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self-management. For example, the
nurse can ask patients which medica-
tions they take to help preserve kid-
ney function. Or the nurse can ask
patients to identify which over-the-
counter medication they keep at
home that are nephrotoxic and
should be avoided to help protect the
kidneys from further injury. 
Conclusion 
Opportunities remain to enhance
patients’ knowledge about CKD and
awareness of CKD diagnoses. Consis -
tent with national trends, in this sam-
ple of patients receiving nephology
care for CKD Stage 3, knowledge
about CKD was moderate, and
awareness of one’s own diagnosis
remain ed substantially low. Know -
ledge and awareness are essential edu-
cational components that can enhance
self-management efforts. Concerted
patient education efforts should be
made to increase patients’ knowledge
about CKD in areas that will best sup-
port self-management and include
understanding the function of the kid-
neys, symptoms associated with
CKD, and how these are associated
with behaviors patients can engage in
that can slow disease progression.
Even more important is a need to
ensure that CKD diagnosis is dis-
closed to patients in a way they under-
stand. Interventions supporting self-
management behaviors are needed,
including ways to enhance pa tient-
provider communication diagnoses.
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